Structural Characterisation of Tpx from Yersinia pseudotuberculosis Reveals Insights into the Binding of Salicylidene Acylhydrazide Compounds

Overview of theCCP4 suite and current developments

(2011) Martyn D. Winn et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

Identification of Bacterial Target Proteins for the Salicylidene Acylhydrazide Class of Virulence-blocking Compounds

(2011) Dai Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

High-frequency transposition for determining antibacterial mode of action

(2011) Hao Wang et al.   Nature Chemical Biology

Features and development ofCoot

(2010) P. Emsley et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

Expression, purification, crystallization and initial X-ray diffraction analysis of thiol peroxidase fromYersinia pseudotuberculosis

(2010) Mads Gabrielsen et al.   Acta Crystallographica Section F-Structural Biology and Crystallization Communications

Antivirulence drugs to target bacterial secretion systems

(2010) Christian Baron   CURRENT OPINION IN MICROBIOLOGY

Thiol Peroxidase Protects Salmonella enterica from Hydrogen Peroxide Stress In Vitro and Facilitates Intracellular Growth

(2010) S. A. Horst et al.   JOURNAL OF BACTERIOLOGY

ALINE: a WYSIWYG protein-sequence alignment editor for publication-quality alignments

(2009) Charles Simon Bond et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

Characterization of the Effects of Salicylidene Acylhydrazide Compounds on Type III Secretion in Escherichia coli O157:H7

(2009) J. J. Tree et al.   INFECTION AND IMMUNITY

Structural Changes Common to Catalysis in the Tpx Peroxiredoxin Subfamily

(2009) Andrea Hall et al.   JOURNAL OF MOLECULAR BIOLOGY

Reversible conformational switch revealed by the redox structures of Bacillus subtilis thiol peroxidase

(2008) Jie Lu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Subcellular localization andin vivooxidation–reduction kinetics of thiol peroxidase inEscherichia coli

(2008) Kazuyuki Tao   FEMS MICROBIOLOGY LETTERS

Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria

(2008) P. Keyser et al.   JOURNAL OF INTERNAL MEDICINE